Cronos Group (CRON) Company Sales Revenue

Cronos Group Inc. (CRON) relies on support from Altria and a unique synthesis of cannabinoids that reduces costs. Efforts to increase profits through premium brands are evident in the company's current sales figures, where the value of 0.21 serves as a baseline metric. However, market oversupply and rising promotion expenses are keeping business margins low.

CRON thecronosgroup.com: Company Revenue in the range 07/04/2022 - 11/14/2026

Analytical breakdowns for Cronos Group Inc.

- stock value and consensus price forecast:

Stock Quotes Cronos Corp|CRON - Price Target Chart

- market capitalization details:

Market Value Cronos Group Inc.|CRON - Total Company Value

- balance sheet net asset value indicators:

Net Asset Value per Share Cronos Group|CRON - Company Book Value|Capitalization to Book Value Ratio thecronosgroup.com|CRON - Aggregate Company Assets

- company liabilities and liquidity data:

- business earnings and investment ratios data:

CRON - Company Net Income|Expected Net Profit Cronos Group Inc.|CRON - Price to Earnings Ratio|Forward P/E Multiple thecronosgroup.com|CRON - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio Cronos Group Inc.|CRON - Operating profit before deduction of amortization|Earnings per share for the trailing year Cronos Group|CRON - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months thecronosgroup.com|CRON - Earnings per share growth in current year|Projected earnings per share growth rate for next year Cronos Group Inc.

- sales volume and revenue indicators:

CRON - Revenue and Sales Volume|Company Future Sales Volume Cronos Corp|CRON - Market Cap to Revenue|Market Cap to Expected Sales Ratio Cronos Group Inc.

General company analysis:Cronos Corp - CRON

Revenue serves as a key indicator of business scaling for Cronos Group Inc. (CRON) across legal cannabis markets. By analyzing the company's total sales on the GURU.Markets platform, investors can observe actual product sales volumes stripped of market noise. This metric captures daily cash inflows from both medical and recreational clients. The price action reflects real demand for branded products in Canada, Israel, and Germany, while a steadily rising curve confirms the resilience of the business model.

Key competitors